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Abstract Using a yeast two-hybrid system, we isolated eight
cDNA clones which interacted with BH-protocadherin-c (BH-
Pcdh-c) from the human brain cDNA library. One clone encoded
protein phosphatase type 1 isoform K (PP1K) and another two
PP1K2. PP1K was co-immunoprecipitated from the extract of a
gastric adenocarcinoma cell line MKN-28 with anti-BH-Pcdh-c
antibody. PP1K activity towards glycogen phosphorylase was
inhibited by the intracellular domain of BH-Pcdh-c. Inhibition of
the phosphatase required more than the minimal domain of BH-
Pcdh-c which could associate with PP1K. In situ hybridization
revealed that BH-Pcdh-c mRNA was predominantly expressed in
cerebral cortex neurons in the adult mouse brain.
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1. Introduction
The cadherin superfamily can be classi¢ed into two groups,
classic type and non-classic type [1,2]. Although the intracel-
lular domain of classic cadherins is well known to associate
with catenins [3], there is little information about the mole-
cules, which interact with that of protocadherins (Pcdhs), the
major non-classic type subfamily [4]. The intracellular domain
of Pcdhs lack the homologous sequence corresponding to the
Lcatenin-binding site described for the classic cadherins [5].
Immunoprecipitation and a⁄nity chromatography experi-
ments showed there is no obvious interaction between Pcdhs
and catenins [4,6]. It is possible that the intracellular domain
of Pcdhs associates with proteins other than catenins. Indeed,
cadherin-related neural receptor, a novel non-classic type sub-
family, was recently identi¢ed to interact with Fyn [7].
Pcdhs were originally isolated from the vertebrate central
nervous system [4]. Many Pcdhs appear to be expressed pre-
dominantly in brain and individual Pcdhs have a character-
istic expression pattern in brain [8^12]. Although Pcdhs seem
to be involved in some highly specialized cell-cell interaction
processes in the central nervous system [4], their biological
functions remain to be identi¢ed.
Previously, we isolated human BH-protocadherin (BH-
Pcdh) which showed overall signi¢cant homology with
Pcdh1 [13]. BH-Pcdh also exhibited 85% identity with Xeno-
pus NF-protocadherin, which was shown to be required for
Xenopus ectodermal di¡erentiation [6]. There are three iso-
forms of BH-Pcdh, denoted -a, -b and -c, which have a di¡er-
ent cytoplasmic tail. Interestingly, the intracellular domain of
BH-Pcdh-c showed similar length and signi¢cant homology
with that of an alternatively spliced product of Pcdh1 [13].
We consider that this well-conserved C-terminus region be-
tween BH-Pcdh-c and Pcdh1 isoform suggests the functional
importance of this region.
To identify novel cellular proteins associated with the intra-
cellular domain of BH-Pcdh-c, we performed yeast two-hybrid
screening using human brain cDNA library. Here we report
the in vitro and in vivo interaction between BH-Pcdh-c and
protein phosphatase type 1 isoform K (PP1K). Furthermore,
we performed in situ hybridization using adult mouse brain
and observed the localization of BH-Pcdh-c mRNA predom-
inant in the cerebral cortex neurons.
2. Materials and methods
2.1. Yeast two-hybrid system
Two-hybrid screening [14] was performed using the Matchmaker
two-hybrid system from Clontech. The intracellular domain of BH-
Pcdh-c (GenBank Accession Number. AB006757; amino acids 848^
1200) was cloned by PCR with primers 5P-CGCCATGGTAGT-
GATGGCAAGGTACTGCAGGTCC-3P and 5P-CGGTCGACGCT-
GTTGCTCCTTTATAGCCTACAGG-3P. The resulting PCR prod-
uct was cleaved with NcoI and SalI and cloned into the
corresponding site of GAL4 DNA binding domain expression vector
pAS2 (Clontech) as a bait. cDNAs derived from human brain mRNA
were directionally subcloned into the EcoRI/XhoI digested GAL4 ac-
tivation domain expression vector pACT2 (Clontech) as a prey. Sac-
charomyces cerevisiae HF7c was transformed by the lithium acetate
method [15] and positive colonies were screened for L-galactosidase
activity using a ¢lter lift assay.
2.2. Stable transfection of human BH-Pcdh-c in L cells
The full-length human BH-Pcdh-c cDNA was digested with FseI
and HindIII in order to remove extra ATG sequences located in the
5P-untranslated region. The 3.8-kb of the fragment including the com-
plete coding sequence was subcloned into the expression vector driven
by the human elongation factor 1K promoter and the human cytome-
galovirus enhancer [16]. For a control, the expression vector without
cDNA insert was also used. LTK3 cells (Riken Cell Bank; No.
RCB0208) were transfected with Lipofectamine (Life Technologies).
After 48 h, the transfected cells were selected with 600 Wg/ml G418
(Wako). Northern blot analysis showed the expression of mRNA of
the expected sizes in the transfected cells and the clones exhibiting
high expression of BH-Pcdh-c were used for the further analysis. Iso-
lated clones were maintained in MEM medium supplemented with
10% bovine calf serum at 37‡C in a 5% CO2 atmosphere.
2.3. Antibody production
Anti-serum was raised in rabbits using a peptide corresponding to a
sequence in the C-terminus of BH-Pcdh-c (EYKPSPVNTLTRREV-
YL) conjugated to keyhole limpet hemocyanin. BH-Pcdh-c antibody
speci¢city was checked by Western blotting using BH-Pcdh-c trans-
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fected L cells. As control, parent L cells or MOCK was used. In the
transfected cells, the expected 160-kDa protein was detected (Fig.
2C).
2.4. Cell extract preparation
Human gastric adenocarcinoma cells MKN28 were grown in RPMI
1640 supplemented with 10% fetal calf serum at 37‡C in a 5% CO2
atmosphere. Con£uent cells were washed twice with cold phosphate-
bu¡ered saline, pH 7.4 (PBS) and scraped on ice in PBS. Collected
cells were incubated in the lysis bu¡er (1% Triton X-100 for immu-
noprecipitation or 1% Nonidet P-40 for pull-down assay, 10 mM Tris-
HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsul-
fonyl £uoride, 10 g/ml leupeptin, 10 g/ml aprotinin) with constant
shaking for 30 min at 4‡C and spun at 12 000 rpm for 30 min. The
supernatant was used as soluble fraction for further experiments.
2.5. Preparation of GST fusion proteins and pull-down assay
To construct GST fusion proteins, amino acids corresponding to
877^1200 (GST-CP), 1009^1200 (GST-RVTF (+)) and 1020^1200
(GST-RVTF (3)) of BH-Pcdh-c were cloned by PCR using the fol-
lowing sense primers: for GST-CP, 5P-CGGAATTCTACACCCCAA-
CAGCATGACAAATCTA-3P ; for GST-RVTF (+), 5P-CGGAATTC-
CAGCAAACAGCCATTTCGTAGAGTGA-3P ; for GST-RVTF (3),
5P-CGGAATTCTGTTGTGAGTCAGCCTCAGGACCCAC-3P and
the common antisense primer: 5P-CGGAATTCGCTGTTGCTCCTT-
TATAGCCTACAGG-3P. The resulting PCR products were cleaved
with EcoRI and cloned into the corresponding site of pGEX-3X
(Pharmacia). The protein was expressed in E. coli DH5K by induction
of log phase cells with 0.1 mM isopropyl-1-thio-L-D-galactopyranoside
at 37‡C for 4 h. Cells were resuspended in ice-cold TNE bu¡er con-
taining 50 mM Tris-HCl, pH 7.4, 50 mM NaCl, 1 mM EDTA and
1 mM dithiothreitol. Following sonication using Branson soni¢er 250,
Triton X-100 was added to 1%. The supernatant was directly added to
glutathione-Sepharose 4B (Pharmacia) and washed extensively with
PBS. The fusion protein was eluted with 16 mM reduced glutathione
in TNE bu¡er. For pull-down experiments, similar quantities of pu-
ri¢ed GST or GST fusion proteins were bound to glutathione-Sephar-
ose 4B beads in binding bu¡er containing 50 mM Tris-HCl, pH 7.4,
5 mM MgCl2, 100 mM NaCl, 10% glycerol, 0.5 mg/ml bovine serum
albumin and 5 mM 2-mercaptoethanol for 1 h at 4‡C. Followed by
washing, the GST fusion protein bound to beads was incubated with
extracts made from MKN28 cells for 1 h at 4‡C, then washed four
times with binding bu¡er to remove unbound proteins. Subsequently,
the speci¢cally bound proteins were eluted with a solution containing
10 mM reduced glutathione in binding bu¡er without bovine serum
albumin and analyzed by Western blotting with anti-PP1K polyclonal
antibody (Upstate Biotechnology; dilution 1:1000) and anti-PP1K
monoclonal antibody (Transduction Laboratories; dilution 1:1000),
respectively. Labeled proteins were detected by Western blot solution
obtained from Promega.
2.6. Immunoprecipitation
The lysates of MKN28 cells or L cells expressing BH-Pcdh-c were
precleared with protein G-Sepharose (Pharmacia) equilibrated in PBS
containing 0.1% bovine serum albumin and 0.05% Tween 20, for 30
min at 4‡C under shaking. After a short spin, the supernatant was
transferred into a new tube and incubated under shaking with the
respective antibody for 1 h at 4‡C. The immunocomplexes were ab-
sorbed to protein G-Sepharose for 1 h at 4‡C and washed four times
in the lysis bu¡er. Associated proteins were then eluted in 2USDS-
PAGE loading bu¡er by boiling for 5 min and analyzed by Western
blotting.
2.7. Protein phosphatase assay
32P-labelled glycogen phosphorylase (Life Technologies) and myelin
basic protein (New England Biolabs) were prepared according to the
manufacturer’s instruction. The speci¢c activity of the [Q-32P]ATP
used for phosphorylation was 106 cpm/nmol. PP1K was purchased
from New England Biolabs. The phosphatase assay (¢nal volume
60 Wl) was carried out with 0.05 Wg/ml of PP1K in 15 mM Tris-
HCl, pH 7.0, 13 mM imidizol-HCl, pH 7.63, 3% L-mercaptoethanol,
0.3 mg/ml of bovine serum albumin, 5 mM ca¡eine, 0.1 mM EDTA,
1 mM MnCl2 with or without varied concentration of GST, GST-CP,
GST-RVTF(+) and GST-RVTF(3). The reaction was initiated by
addition of 1 mg/ml 32P-labelled substrate, carried out for 10 min at
30‡C and stopped by trichloroacetic acid to a ¢nal concentration of
15%. Cherenkov counting determined radioactivity present in the
supernatant.
2.8. Animals and section preparation
Male mice (C57BL/6J), at 10 weeks of age, were killed with pento-
barbital. The brain was removed and ¢xed with 4% paraformaldehyde
(PFA)/PBS for 24 h followed by 30% sucrose/PBS for 24 h. The thin
sections (20 Wm) were air dried on gelatin-coated glass slides and
subjected to 4% PFA/PBS ¢xation for 15 min at room temperature.
2.9. In situ hybridization
Antisense and sense digoxigenin (DIG)-labeled cRNA probes were
synthesized using the DIG RNA labeling kit (Boehringer Mannheim).
As template, the 0.6-kb coding region of BH-Pcdh-c (nucleotides
3879^4477) subcloned in the EcoRI site of pBluescript SK(3) was
used. DIG-labeled cRNA was detected using the DIG nucleic acid
detection kit (Boehringer Mannheim). Brie£y, each section was incu-
bated with alkaline phosphatase-conjugated anti-DIG antibody (dilu-
tion 1:3000) at room temperature for 1 h and phosphatase activity
visualized with NBT/BCIP (nitro blue tetrazolium/5-bromo-4-chloro-
3-indolyl-phosphate). The sections were then counter-stained with
methyl green.
3. Results
3.1. Identi¢cation of a novel cellular protein interacting with
the intracellular domain of BH-Pcdh-c
To identify cellular proteins capable of interacting with the
Fig. 1. In vitro association of PP1K with the intracellular domain of
BH-Pcdh-c. A: Schematic diagram of the intracellular domain of
BH-Pcdh-c used in the pull-down assay. BH-Pcdh-c fragments con-
taining almost the full-length cytoplasmic region (CP) and the C-ter-
minus half region with (+) or without (3) RVTF sequence are
aligned with the full length BH-Pcdh-c intracellular domain. Num-
bers indicate amino acid positions with respect to the original BH-
Pcdh-c sequence. Positions of the splice site (1012th amino acid) are
indicated. B: To perform pull-down assay, amino acid 877^1200
(GST-CP), 1009^1200 (GST-RVTF(+)) and 1020^1200 (GST-RVTF
(3)) of BH-Pcdh-c were fused to GST. GST fusion proteins were
bound to glutathione-Sepharose beads in binding bu¡er and incu-
bated with MKN28 cell lysates. Following extensive washing, com-
plexes eluted from beads were subjected to Western blotting with
rabbit polyclonal (pAb) and mouse monoclonal (mAb) anti-PP1K
antibody. GST alone was used as a negative control. The speci¢c
37-kDa band is indicated by the arrow on the right. The relative
molecular weights of prestained molecular weight markers are noted
on the left.
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intracellular domain of BH-Pcdh, we performed yeast two-
hybrid screening [14]. We initially used the intracellular do-
main of BH-Pcdh-a as bait to screen a human brain cDNA
library. Although a total of 1.8U106 HF7c transformants
were subjected to HIS3 selection/lacZ screen, we could not
isolate any positive clone. On the other hand, eight positive
clones were identi¢ed when using the intracellular domain of
BH-Pcdh-c as bait. Sequence analysis revealed that one of the
isolated clones encoded PP1K and two other encoded PP1K2,
which di¡ers from PP1K by an N-terminal 11-amino-acid in-
sert [14]. These isolated three clones encoded the entire open
reading frame of PP1K and PP1K2, respectively. Others were
BAI1-associated protein [17] and rat MUPP1 [18] homolog
which have 5 and 13 PDZ domains, respectively, and a novel
protein which showed overall 50% amino acids identity with
previously reported putative G-protein, GP-1 [19], and Tip60
[20] and the rest were unknown genes.
Recent study has revealed that the PP1-binding proteins
interact with the catalytic subunit of PP1 through their -(R/
K)(V/I) XF-consensus motif [21]. We found a RVTF sequence
that is similar to the consensus motif for PP1-binding protein
at residues 1015^1018 of BH-Pcdh-c. This sequence is present
only in BH-Pcdh-c because BH-Pcdh-a and -b are alterna-
tively spliced at residues 1011 and 1012. From these observa-
tions, we selected PP1K for further experiments.
3.2. In vitro association of PP1Kwith the intracellular domain
of BH-Pcdh-c
To obtain further evidence about the interaction between
BH-Pcdh-c and PP1K, we produced the intracellular domain
of BH-Pcdh-c as GST fusion proteins and performed a pull-
down assay using endogenous PP1K present in the lysates of
human cells MKN28. C-terminus fragment of BH-Pcdh-c
comprising 324 (GST-CP), 192 (GST-RVTF(+)) and 181
(GST-RVTF(3)) amino acids were expressed in E. coli as
GST fusion protein (Fig. 1A). Equal amounts of puri¢ed
GST fusion proteins and GST alone were bound to gluta-
thione-Sepharose beads and incubated with extracts made
from MKN28 cells. Pulled-down proteins were subjected to
SDS-PAGE, blotted to PVDF membrane and detected with
Fig. 2. In vivo association of PP1K with BH-Pcdh-c. L cells expressing BH-Pcdh-c (A) and MKN28 cells (B) were lysed and incubated with the
indicated antibody (upper side) and protein G-Sepharose. Following extensive washing, complexes were assayed for PP1K content by Western
blotting with an anti-PP1K monoclonal antibody (mAb). To con¢rm the speci¢city of immunoprecipitation for anti-BH-Pcdh-c antibody, syn-
thetic peptide corresponding to the C-terminus of BH-Pcdh-c was added to the anti-BH-Pcdh-c antibody before immunoprecipitation (lane 1 of
A). The cell lysates and anti-PP1KmAb immunoprecipitates were used for con¢rming the position of PP1K. The speci¢c 37-kDa band is indi-
cated by the arrow on the right. C: Immunoblot analysis of BH-Pcdh-c transfected L (LTK3) cells. The cell extracts were subjected to Western
blotting. Anti-BH-Pcdh-c antibody stained a 160-kDa band only in BH-Pcdh-c transfectant, but not in parent or MOCK transfected cells (left
panel). Pre-bleed detected no bands in any cells (right panel). The 160-kDa band is indicated by the arrow on the left. The positions of molecu-
lar size standards are shown on the left.
Fig. 3. Modulation of phosphatase activity by the intracellular domain of BH-Pcdh-c. Assay was performed with the catalytic subunit of PP1K
and 0^1 WM range of GST, GST-CP, GST-RVTF(+) or GST-RVTF(3). Increasing concentration of GST-CP produced a potent inhibition of
PP1K activity towards the phosphorylase (A) that was not seen towards myelin basic protein (B). Results were calculated as percentage of ac-
tivity seen in the absence of added GST fusion protein.
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two di¡erent anti-PP1K antibodies. PP1K was most obvious
when GST-CP which encodes almost the full length of intra-
cellular domain of BH-Pcdh-c was used for pull-down assay
(Fig. 1B). In contrast, GST-RVTF (+) which encodes the
residues 1009^1200 of BH-Pcdh-c including the consensus mo-
tif for PP1-binding protein showed a weak signal when com-
pared with that of GST-CP. GST-RVTF(3), which lacks 11
amino acids including the consensus motif, showed no signal
for PP1K (Fig. 1B). GST alone could not pull-down with
PP1K (Fig. 1B).
From these observations, PP1K present in the lysates of
MKN28 cells can associate with the intracellular domain of
BH-Pcdh-c. The RVTF sequence located on the intracellular
domain of BH-Pcdh-c may function as the binding site de-
scribed on PP1-binding proteins.
3.3. In vivo association of PP1Kwith BH-Pcdh-c
To obtain another indication of the protein-protein inter-
action suggested by the two-hybrid system and in vitro pull-
down results, we examined the ability of the protein product
of BH-Pcdh-c to co-immunoprecipitate with PP1K in mamma-
lian cell lysates. At ¢rst, BH-Pcdh-c was subcloned into a
mammalian expression vector and expressed stably to a high
level in mouse ¢broblast L cells. Isolated clones showed lon-
ger shape when compared with parent or MOCK-transfected
L cells (data not shown). Using these cells and an antibody
directed against the C-terminus of BH-Pcdh-c, a molecular
mass of approximately 160-kDa protein was observed for
BH-Pcdh-c (Fig. 2C). Immunoprecipitation was carried out
using this anti-BH-Pcdh-c antibody or pre-immune serum.
Protein present in the immune complex was subjected to
Western blotting using an anti-PP1K monoclonal antibody.
The complex between PP1K and exogenous BH-Pcdh-c pro-
tein was co-immunoprecipitated with anti-BH-Pcdh-c anti-
body, but not with pre-immune serum (Fig. 2A). Pre-absorp-
tion of anti-BH-Pcdh-c antibody with the synthetic peptide
was used for the production of antibody inhibited the co-im-
munoprecipitation of PP1K (Fig. 2A).
Fig. 4. Localization of BH-Pcdh-c mRNA in cerebral cortex of adult mouse brain. (A,C) In situ hybridization with an antisense BH-Pcdh-c cy-
toplasmic tail riboprobe (599-bp) revealed BH-Pcdh-c mRNA is predominantly expressed in cerebral cortex neurons. (B,D) As a control, mouse
brain hybridized with a sense riboprobe showed no signals. The sections were incubated with alkaline phosphatase-conjugated anti-DIG anti-
body and visualized with NBT/BCIP. The sections were also counterstained with methyl green (C,D). Arrows indicate positive signals (C).
Magni¢cations were 100U (A,B) and 400U (C,D), respectively.
FEBS 22747 11-10-99
K. Yoshida et al./FEBS Letters 460 (1999) 93^9896
Next, we examined whether these two proteins could be co-
immunoprecipitated when BH-Pcdh-c is expressed at its en-
dogenous level in human cells. For this purpose, we used
MKN28 cells because BH-Pcdh-c was originally isolated
from them [13]. Immunoblot analysis showed that PP1K was
found in the immunocomplex precipitated by anti-BH-Pcdh-c
antibody (Fig. 2B). These results suggest that the two proteins
associate with each other in mammalian cells.
3.4. Modulation of phosphatase activity by the intracellular
domain of BH-Pcdh-c
To see the e¡ect of association of BH-Pcdh-c on PP1K
activity, the intracellular domain of BH-Pcdh-c was bacterial-
ly expressed as described above. Their e¡ect on the activity of
PP1K was examined using 32P-labelled glycogen phosphoryl-
ase or myelin basic protein as substrate. Fig. 3A shows that
GST-CP inhibited PP1K enzymatic activity towards the stand-
ard substrate, glycogen phosphorylase, normally used to assay
PP1 with an IC50 of V10 nM. In contrast, GST-RVTF(+)
which could associate with PP1K showed only slight e¡ect on
the activity of PP1K. GST-RVTF (+) was slightly more e¡ec-
tive than GST-RVTF(3) at higher concentrations (Fig. 3A).
GST alone had no e¡ect on the activity of PP1K at any con-
centrations. On the other hand, PP1K activity towards myelin
basic protein was weakly suppressed by the intracellular do-
main of BH-Pcdh-c (Fig. 3B).
3.5. Localization of BH-Pcdh-c mRNA in cerebral cortex of
adult mouse brain
Previously, we detected BH-Pcdh mRNA predominantly in
the brain and heart by Northern blot analysis [13]. To deter-
mine the cellular localization of BH-Pcdh-c mRNA in the
adult mouse brain, we performed in situ hybridization analy-
sis. Using DIG-labelled antisense RNA complementary to the
cytoplasmic tail region of BH-Pcdh-c as a probe, we detected
BH-Pcdh-c mRNA predominantly in the cerebral cortex (Fig.
4A) and weakly in septum, thalamus, substantia nigra, pons
and spinal cord. Other segments of brain such as caudoputa-
men, cerebellum and hippocampus did not show any signal
(data not shown). In cerebral cortex, speci¢c signal for BH-
Pcdh-c mRNA overlapped with the comparatively larger nu-
clei, namely neurons (Fig. 4C). No speci¢c signal was ob-
served in adjacent sections hybridized with the sense RNA
probe (Fig. 4B and D).
4. Discussion
We performed a yeast two-hybrid screen using human brain
cDNA library for candidate proteins that interact with the
intracellular domain of BH-Pcdh-c. We isolated eight clones
including signal transduction molecules, such as PP1K, multi-
PDZ domain containing protein and a novel protein contain-
ing a GTP-binding motif (data not shown). The possibility of
interaction between BH-Pcdh-c and PP1K seems to be reason-
able because three out of eight clones encoded the same gene
product, the catalytic subunit of the serine/threonine phospha-
tase of type 1 (PP1) isoform K and K2. Further, BH-Pcdh-c
contained the consensus binding motif -(R/K)(V/I)XF- for
PP1-binding protein at residues 1015^1018 [21].
PP1 consists of a catalytic subunit with various kinds of the
targeting (or regulatory) subunits, in vivo. For the catalytic
subunit of PP1 (PP1c), there are 5 isoforms:K, K2,Q, Q2, and
c[14,22]. The binding protein, termed targeting (or regulatory)
subunit, determines the substrate speci¢city and subcellular
localization of PP1c [23]. At present, a number of targeting
subunits have been identi¢ed and characterized [23]. Recently,
PP1c was reported to associate with focal adhesions including
alpha v integrin [24]. But the binding of PP1c to a cadherin
superfamily molecule has not yet been reported.
From in vitro pull-down experiments, interaction between
BH-Pcdh-c and PP1K was observed when the intracellular
domain of BH-Pcdh-c was fused to the GST. However,
when residues 1020^1200 of BH-Pcdh-c were used for the
pull-down assay, the binding of BH-Pcdh-c with PP1K was
undetected. We suggest that the consensus motif for PP1-
binding protein found in BH-Pcdh-c is at least required for
the interaction with PP1K, although the full length intracellu-
lar domain of BH-Pcdh-c may be required for strong binding
with PP1K in vitro.
The association between BH-Pcdh-c and PP1K was veri¢ed
by yeast two-hybrid screening and pull-down assay. Further-
more, we performed immunoprecipitation experiment to ob-
tain another line of evidence which suggests that the complex
between BH-Pcdh-c and PP1K exists in mammalian cells.
PP1K was co-immunoprecipitated from L cells expressing
exogenous BH-Pcdh-c with anti-BH-Pcdh-c antibody. More-
over, PP1K presented in MKN28 cells was co-immunopreci-
pitated with anti-BH-Pcdh-c antibody. These results indicate
that the complex of two proteins exist in mammalian cells.
The complex between PP1K and BH-Pcdh-c modulates the
phosphatase activity of PP1K. The intracellular domain of
BH-Pcdh-c fused to the GST inhibited PP1K enzymatic activ-
ity towards glycogen phosphorylase. On the other hand, res-
idues 1009^1200 of BH-Pcdh-c which could associate with
PP1K showed only a slight e¡ect on the PP1K activity.
PP1K enzymatic activity towards myelin basic protein was
weakly suppressed by the intracellular domain of BH-Pcdh-
c. The substrate-speci¢c e¡ect of BH-Pcdh-c on PP1K suggests
that the inhibition observed could be regulatory and not a
non-speci¢c suppression of phosphatase activity.
PP1K is known to be higher expressed in brain than in other
tissues [25,26]. In neurons, PP1K has been implicated in long-
term synaptic plasticity [27,28]. We therefore examined the
localization of BH-Pcdh-c mRNA in adult mouse brain.
From in situ hybridization analysis, BH-Pcdh-c mRNA was
predominantly expressed in cerebral cortex neurons. There is
accumulating evidence that the classical cadherins and cadher-
in-related neural receptor are involved in synaptic transmis-
sion and plasticity [1,29]. Further analysis is required to
understand the physiological signi¢cance of the complex be-
tween BH-Pcdh-c and PP1K.
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